MedPath

BIOBAY� NERVOPANE CAPSULE

Registration Number: MAL20116137NC

Approved
Approval ID

53f7c571a6617133

Registration Number

MAL20116137NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types7 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (7)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
6 CapsulesAvailable
Package Size: 6 Capsules
Status: NPRA Approved
20 CapsulesAvailable
Package Size: 20 Capsules
Status: NPRA Approved
10 CapsulesAvailable
Package Size: 10 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (9)

ALPHA LIPOIC ACIDActive
Monograph: 硫辛酸
PYRIDOXINE HYDROCHLORIDEActive
Monograph: 维生素B6
ZINC METHIONINEActive
Monograph: zinc methionine
Vitamin D3 (Cholecalciferol)Active
Monograph: vitamin d 3 (cholecalciferol)
BENFOTIAMINEActive
Monograph: 苯磷硫胺
CHROMIUM POLYNICOTINATEActive
Monograph: chromium polynicotinate
METHYLCOBALAMINActive
Monograph: 甲钴胺
D-CALCIUM PANTOTHENATEActive
Monograph: d-calcium pantothenate
INOSITOLActive
Monograph: 肌醇

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BIOBAY� NERVOPANE CAPSULE - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform